CCM
ABMD

Catapult Capital Management’s Abiomed Inc ABMD Stock Holding History

Catapult Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-115,000
Closed -$2.85M – 229
2014
Q3 		$2.85M Buy
+115,000
New +$2.91M 0.31% 101

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Catapult Capital Management's ABMD Position: Q4 2014 in Review

Catapult Capital Management sold out of Abiomed Inc (ABMD) in Q4 2014, closing a stake of 115,000 shares — an estimated $2.85M sold.

Catapult Capital Management first reported a position in ABMD in Q3 2014 and held it in 1 quarter. The position peaked at $2.85M in Q3 2014. 158 funds tracked by Wall St. Rank hold ABMD as of Q4 2014.

  • Catapult Capital Management reported no remaining Abiomed Inc position as of Q4 2014 after selling out during the quarter.
  • Catapult Capital Management sold 115,000 Abiomed Inc shares in Q4 2014, an estimated $2.85M.
  • Catapult Capital Management first reported a position in Abiomed Inc in Q3 2014 and held it in 1 quarter.
  • Catapult Capital Management's Abiomed Inc position peaked at $2.85M in Q3 2014.
  • 158 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2014.

Based on Catapult Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.